MannKind Corporation (MNKD) vs Replimune Group, Inc. (REPL)
- MannKind Corporation MNKD 3.04 −4.70%
- Replimune Group, Inc. REPL 10.86 −7.57%
MannKind Corporation and Replimune Group, Inc. are both Biotechnology companies. MannKind Corporation and Replimune Group, Inc. are of similar size ($1.1B and $1.0B). Replimune Group, Inc. has the higher net margin (0.00% vs −11.1%) and the lower return on invested capital (−1,154.7% vs 2.36%). Across the 13 metrics below, MannKind Corporation leads on 8 and Replimune Group, Inc. on 5.
Valuation
Profitability
| Metric | MNKD | REPL | Biotechnology median |
|---|---|---|---|
| Gross margin | 75.39% | 0.00% | 65.16% |
| Operating margin | 2.34% | 0.00% | 0.00% |
| Net margin | (11.08%) | 0.00% | 0.00% |
| Free cash flow margin | (4.61%) | 0.00% | 0.00% |
| Return on equity | 71.36% | (134.29%) | (56.36%) |
| Return on assets | (7.62%) | (82.28%) | (48.04%) |
| Return on invested capital | 2.36% | (1,154.69%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack